Bon Secours Cancer Institute — Midlothian, Virginia

Bon Secours Cancer Institute is a clinical research site located in Midlothian, Virginia, United States 23114.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Bon Secours Cancer Institute has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer.

Sponsors: Atossa Therapeutics, Inc., Genomic Health®, Inc., Australasian Gastro-Intestinal Trials Group.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bon Secours Cancer Institute?

Bon Secours Cancer Institute has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bon Secours Cancer Institute conducted?

Bon Secours Cancer Institute has 4 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer.

Is Bon Secours Cancer Institute accredited by Crixeo Health?

Bon Secours Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bon Secours Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.